Position in GERN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$241,397
+$80,878 QoQ
Shares Held
188,592
+75.1% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. GERN ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,397 | 188,592 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $160,519 | 107,731 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $168,994 | 128,026 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $159,106 | 116,136 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $209,056 | 148,267 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $249,264 | 156,770 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $690,986 | 195,194 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $660,987 | 145,592 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $446,217 | 105,240 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $430,042 | 130,316 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $252,151 | 119,503 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $209,695 | 98,913 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $313,584 | 97,690 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $175,079 | 80,682 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $189,413 | 78,270 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $167,040 | 71,385 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $108,120 | 69,755 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $123,031 | 90,464 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $136,537 | 111,916 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $146,769 | 107,131 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $191,008 | 135,467 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $189,182 | 119,736 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $177,374 | 111,556 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $148,340 | 85,253 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $162,013 | 74,318 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $45,628 | 38,343 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||